The data is pseudonymous and apparently can't be linked to actual people.

Last week Danish pharmaceutical company Novo Nordisk, the maker of the popular diabetes and weight-loss drugs Ozempic and ...

AI in clinical trials holds great promise for the entire drug development lifecycle. However, any new technology should ...

Critical Path Institute® (C-Path), through its Type 1 Diabetes Consortium, today reaffirmed its commitment to strengthening ...

What happened Novo Nordisk disclosed a cybersecurity incident involving unauthorized access to a limited number of internal IT systems, which resulted in certain clinical trial patient data being ...

A new analysis found that results for less than half of the clinical studies registered in a key European database were ...

In the last decade, the volume of clinical trial data has surged, presenting unprecedented challenges for sponsors and contract research organizations (CROs). The task of collecting, cleaning, ...

The most underestimated category, and the one with the most long-term potential, is clinical-driven AI, where the model is ...

Novo Nordisk said the breach involved a limited amount of information relating to patients enrolled in certain clinical ...

June 11 (Reuters) - Novo Nordisk said on Thursday it has identified a security incident in which certain information, ...

This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Clinical trials represent a significant ...

Faculty in this hub lead the design, coordination, and analysis of clinical trials for cancer treatment, survivorship, vaccine efficacy, infectious disease prevention and treatment, and cancer ...